Authors:
Kivipelto, M
Helkala, EL
Laakso, MP
Hanninen, T
Hallikainen, M
Alhainen, K
Soininen, H
Tuomilehto, J
Nissien, A
Citation: M. Kivipelto et al., Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BR MED J, 322(7300), 2001, pp. 1447-1451
Authors:
Clarke, NA
Soininen, H
Gustafson, L
Minthon, L
Alhainen, K
Francis, PT
Citation: Na. Clarke et al., Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients, INT J GER P, 16(11), 2001, pp. 1104-1106
Citation: P. Kerokoski et al., beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality, NEUROCHEM I, 38(2), 2001, pp. 127-134
Authors:
Hiltunen, M
Mannermaa, A
Thompson, D
Easton, D
Pirskanen, M
Helisalmi, S
Koivisto, AM
Lehtovirta, M
Ryynanen, M
Soininen, H
Citation: M. Hiltunen et al., Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland, NEUROLOGY, 57(9), 2001, pp. 1663-1668
Authors:
Winblad, B
Engedal, K
Soininen, H
Verhey, F
Waldemar, G
Wimo, A
Wetterholm, AL
Zhang, R
Haglund, A
Subbiah, P
Citation: B. Winblad et al., A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD, NEUROLOGY, 57(3), 2001, pp. 489-495
Authors:
Vanhanen, M
Kivipelto, M
Koivisto, K
Kuusisto, J
Mykkanen, L
Helkala, EL
Hanninen, T
Kervinen, K
Kesaniemi, YA
Laakso, MP
Soininen, H
Laakso, M
Citation: M. Vanhanen et al., APOE-epsilon 4 is associated with weight loss in women with AD - A population-based study, NEUROLOGY, 56(5), 2001, pp. 655-659
Authors:
Kivipelto, M
Helkala, EL
Hanninen, T
Laakso, MP
Hallikainen, M
Alhainen, K
Soininen, H
Tuomilehto, J
Nissinen, A
Citation: M. Kivipelto et al., Midlife vascular risk factors and late-life mild cognitive impairment - A population-based study, NEUROLOGY, 56(12), 2001, pp. 1683-1689
Authors:
Finnila, S
Autere, J
Lehtovirta, M
Hartikainen, P
Mannermaa, A
Soininen, H
Majamaa, K
Citation: S. Finnila et al., Increased risk of sensorineural hearing loss and migraine in patients witha rare mitochondrial DNA variant 4336A > G in tRNA(Gln), J MED GENET, 38(6), 2001, pp. 400-405
Authors:
Kerokoski, P
Suuronen, T
Salminen, A
Soininen, H
Pirttila, T
Citation: P. Kerokoski et al., The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis, BIOC BIOP R, 280(4), 2001, pp. 998-1002
Authors:
Waldemar, G
Winblad, B
Engedal, K
Soininen, H
Verhey, F
Wimo, A
Wetterholm, AL
Zhang, R
Haglund, A
Subbiah, P
Citation: G. Waldemar et al., Benefits of donepezil on cognition, function and neuropsychiatric symptomsin patients with mild and moderate Alzheimer's disease over one year, ALZHEIMER'S DISEASE, 2001, pp. 725-738
Authors:
Kraszpulski, M
Soininen, H
Helisalmi, S
Alafuzoff, I
Citation: M. Kraszpulski et al., The load and distribution of beta-amyloid in brain tissue of patients withAlzheimer's disease, ACT NEUR SC, 103(2), 2001, pp. 88-92
Authors:
Lehtovirta, M
Partanen, J
Kononen, M
Hiltunen, J
Helisalmi, S
Hartikainen, P
Riekkinen, P
Soininen, H
Citation: M. Lehtovirta et al., A longitudinal quantitative EEG study of Alzheimer's disease: Relation to apolipoprotein E polymorphism, DEMENT G C, 11(1), 2000, pp. 29-35
Authors:
Hiltunen, M
Helisalmi, S
Mannerma, A
Alafuzoff, I
Koivisto, AM
Lehtovirta, M
Pirskanen, M
Sulkava, R
Verkkoniemi, A
Soininen, H
Citation: M. Hiltunen et al., Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?, EUR J HUM G, 8(4), 2000, pp. 259-266
Authors:
Pihlajamaki, M
Tanila, H
Hanninen, T
Kononen, M
Laakso, M
Partanen, K
Soininen, H
Aronen, HJ
Citation: M. Pihlajamaki et al., Verbal fluency activates the left medial temporal lobe: A functional magnetic resonance imaging study, ANN NEUROL, 47(4), 2000, pp. 470-476
Authors:
Mikkonen, M
Pitkanen, A
Soininen, H
Alafuzoff, I
Miettinen, R
Citation: M. Mikkonen et al., Morphology of spiny neurons in the human entorhinal cortex: Intracellular filling with lucifer yellow, NEUROSCIENC, 96(3), 2000, pp. 515-522
Authors:
Helisalmi, S
Valve, R
Karvonen, MK
Hiltunen, M
Pirskanen, M
Mannermaa, A
Koulu, M
Pesonen, U
Uusitupa, M
Soininen, H
Citation: S. Helisalmi et al., The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E, NEUROSCI L, 287(1), 2000, pp. 25-28
Authors:
Tapiola, T
Pirttila, T
Mikkonen, M
Mehta, PD
Alafuzoff, I
Koivisto, K
Soininen, H
Citation: T. Tapiola et al., Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease, NEUROSCI L, 280(2), 2000, pp. 119-122
Authors:
Helisalmi, S
Hiltunen, M
Mannermaa, A
Koivisto, AM
Lehtovirta, M
Alafuzoff, I
Ryynanen, M
Soininen, H
Citation: S. Helisalmi et al., Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease?, NEUROSCI L, 278(1-2), 2000, pp. 65-68
Authors:
Koivisto, AM
Lempiainen, P
Koivisto, K
Helkala, EL
Mykkanen, L
Kuusisto, J
Kervinen, K
Kesaniemi, YA
Laakso, M
Soininen, H
Citation: Am. Koivisto et al., Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: A population-based longitudinal study, NEUROEPIDEM, 19(6), 2000, pp. 327-332
Authors:
Tapiola, T
Pirttila, T
Mehta, PD
Alafuzoff, I
Lehtovirta, M
Soininen, H
Citation: T. Tapiola et al., Relationship between apoE genotype and CSF beta-amyloid (1-42) and tan in patients with probable and definite Alzheimer's disease, NEUROBIOL A, 21(5), 2000, pp. 735-740
Authors:
Lehtovirta, M
Laakso, MP
Frisoni, GB
Soininen, H
Citation: M. Lehtovirta et al., How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies, NEUROBIOL A, 21(2), 2000, pp. 293-300
Authors:
Savolainen, S
Laakso, MP
Paljarvi, L
Alafuzoff, I
Hurskainen, H
Partanen, K
Soininen, H
Vapalahti, M
Citation: S. Savolainen et al., MR imaging of the hippocampus in normal pressure hydrocephalus: Correlations with cortical Alzheimer's disease confirmed by pathologic analysis, AM J NEUROR, 21(2), 2000, pp. 409-414